Hayden Royal, LLC - NEUROBO PHARMACEUTICALS INC ownership

NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hayden Royal, LLC ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$91,000
-12.5%
20,642
+4.3%
0.05%
-8.8%
Q4 2020$104,000
-18.1%
19,792
-12.7%
0.06%
-16.2%
Q3 2020$127,000
-99.9%
22,6820.0%0.07%
-34.0%
Q2 2020$182,591,000
-42.1%
22,6820.0%0.10%
-44.3%
Q1 2020$315,280,000
-51.1%
22,682
-33.6%
0.18%
-43.3%
Q4 2019$644,560,00034,1760.33%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 182,543$1,026,0000.15%
Hayden Royal, LLC 22,682$127,0000.07%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 6,454$36,0000.00%
UBS Group AG 1,913$11,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,559$14,0000.00%
BANK OF AMERICA CORP /DE/ 2,012$11,0000.00%
Russell Investments Group, Ltd. 28,597$160,0000.00%
WELLS FARGO & COMPANY/MN 1,337$7,0000.00%
NORTHERN TRUST CORP 85,444$479,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders